Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07456670) titled 'Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Queen's University
Condition:
Preterm Birth
Caffeine
Neonatal Outcomes
Intervention:
Drug: Caffeine
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 1, 2026
Target Sample Size: 62
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrial...